A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

Paolo Strati, Loretta J. Nastoupil, Richard E. Davis, Luis E. Fayad, Nathan Fowler, Fredrick B. Hagemeister, Larry Kwak, Yasuhiro Oki, Michael Wang, Jason Westin, Charnelle E. Ruben, Emily T. Wesson, Richard Piekarz, Michelle A. Fanale, Hun Ju Lee

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)E26-E28
JournalHaematologica
Volume105
Issue number1
DOIs
StatePublished - Jan 1 2020

ASJC Scopus subject areas

  • Hematology

Cite this

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas. / Strati, Paolo; Nastoupil, Loretta J.; Davis, Richard E.; Fayad, Luis E.; Fowler, Nathan; Hagemeister, Fredrick B.; Kwak, Larry; Oki, Yasuhiro; Wang, Michael; Westin, Jason; Ruben, Charnelle E.; Wesson, Emily T.; Piekarz, Richard; Fanale, Michelle A.; Lee, Hun Ju.

In: Haematologica, Vol. 105, No. 1, 01.01.2020, p. E26-E28.

Research output: Contribution to journalLetter

Strati, P, Nastoupil, LJ, Davis, RE, Fayad, LE, Fowler, N, Hagemeister, FB, Kwak, L, Oki, Y, Wang, M, Westin, J, Ruben, CE, Wesson, ET, Piekarz, R, Fanale, MA & Lee, HJ 2020, 'A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas', Haematologica, vol. 105, no. 1, pp. E26-E28. https://doi.org/10.3324/haematol.2019.220012
Strati, Paolo ; Nastoupil, Loretta J. ; Davis, Richard E. ; Fayad, Luis E. ; Fowler, Nathan ; Hagemeister, Fredrick B. ; Kwak, Larry ; Oki, Yasuhiro ; Wang, Michael ; Westin, Jason ; Ruben, Charnelle E. ; Wesson, Emily T. ; Piekarz, Richard ; Fanale, Michelle A. ; Lee, Hun Ju. / A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas. In: Haematologica. 2020 ; Vol. 105, No. 1. pp. E26-E28.
@article{fdd7ee570957416ca4411020bb58a737,
title = "A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas",
author = "Paolo Strati and Nastoupil, {Loretta J.} and Davis, {Richard E.} and Fayad, {Luis E.} and Nathan Fowler and Hagemeister, {Fredrick B.} and Larry Kwak and Yasuhiro Oki and Michael Wang and Jason Westin and Ruben, {Charnelle E.} and Wesson, {Emily T.} and Richard Piekarz and Fanale, {Michelle A.} and Lee, {Hun Ju}",
year = "2020",
month = "1",
day = "1",
doi = "10.3324/haematol.2019.220012",
language = "English (US)",
volume = "105",
pages = "E26--E28",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "1",

}

TY - JOUR

T1 - A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

AU - Strati, Paolo

AU - Nastoupil, Loretta J.

AU - Davis, Richard E.

AU - Fayad, Luis E.

AU - Fowler, Nathan

AU - Hagemeister, Fredrick B.

AU - Kwak, Larry

AU - Oki, Yasuhiro

AU - Wang, Michael

AU - Westin, Jason

AU - Ruben, Charnelle E.

AU - Wesson, Emily T.

AU - Piekarz, Richard

AU - Fanale, Michelle A.

AU - Lee, Hun Ju

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85077403279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077403279&partnerID=8YFLogxK

U2 - 10.3324/haematol.2019.220012

DO - 10.3324/haematol.2019.220012

M3 - Letter

C2 - 31073068

AN - SCOPUS:85077403279

VL - 105

SP - E26-E28

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 1

ER -